Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

The Longevity Centers of America Offers $175 Risk-Free Initial Consultation for New Patients
Healthcare & PharmaceuticalCompany Update

The Longevity Centers of America Offers $175 Risk-Free Initial Consultation for New Patients

April 16, 2026 10:00 AM

The Longevity Centers of America (LCOA) is spreading awareness about its low-cost integrative medicine consultation, which increases access to longevity care for individuals starting at square one of their integrative or functional health journey.The longevity medicine consultation is physician-supervised and an ideal choice for those with chronic health concerns who want a guided, low-pressure starting point to integrative and/or functional...

Read more
Medical Care Technologies (OTC PINK:MDCE) Reaffirms Commitment to AI-Driven Medical Innovation Following Successful Consumer App Launch
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies (OTC PINK:MDCE) Reaffirms Commitment to AI-Driven Medical Innovation Following Successful Consumer App Launch

April 16, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("MDCE" or the "Company"), a technology-driven innovator in artificial intelligence and healthcare solutions, today reaffirmed its strategic commitment to advancing its core AI-powered medical research initiatives following the successful launch and early traction of its consumer-facing mobile application, Snapshot Recipes. Over the past several months, the Company has successfully demonstrated...

Read more
Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences
Healthcare & PharmaceuticalMergers and Acquisitions

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences

April 16, 2026 9:00 AM

Strados Labs, the respiratory endpoint intelligence company, today announced the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados' suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) - complementing its existing technologies for cough monitoring and lung sound monitoring to create a unique end-to-end...

Read more
CVS Caremark Advances Prior Authorization to Get Specialty Medications to Patients Faster
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Caremark Advances Prior Authorization to Get Specialty Medications to Patients Faster

April 16, 2026 9:00 AM

Key pointsA faster, easier prior authorization experience ensures providers can focus on their patients, helps ensure members get their medications quicklyCVS Caremark is using Surescripts Touchless Prior Authorization for select specialty drugsThe expansion of Touchless Prior Authorization into specialty drugs helps members start treatment sooner, improving medication adherence and health outcomesOriginally published on CVS Health Company...

Read more
KIFFIK Biomedical Establishes Strategic Partnership with Beacon MedTech Solutions to Commercialize its K-EXP(TM) Platform
Healthcare & PharmaceuticalCompany Update

KIFFIK Biomedical Establishes Strategic Partnership with Beacon MedTech Solutions to Commercialize its K-EXP(TM) Platform

April 16, 2026 8:30 AM

KIFFIK Biomedical Inc. ("KIFFIK"), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be available in the second half of 2026, with the scalable production of its next-generation device beginning in mid-2027. The partnership marks a shift from development to execution, aligning...

Read more
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue
Healthcare & PharmaceuticalMergers and Acquisitions

Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

April 16, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced it has entered into a Letter of Intent (LOI) to acquire Dura Driver Control Systems ("DCS"), a premier designer and manufacturer of automotive driver control systems that also apply to other industrial applications. Management of DCS will be bolstered by the...

Read more
The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal
Healthcare & PharmaceuticalCompany Update

The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal

April 16, 2026 8:15 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - At last year's ISHLT congress, in April 2025, the one-year results from the European multicenter heart trial, NIHP2019, were presented. The results have now been published in the European Heart Journal[1].As previously communicated, the long-term analysis of the NIHP2019 trial evaluated patient outcomes 12 months post-transplantation. The findings revealed that severe complications occurred in...

Read more
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Healthcare & PharmaceuticalExchange Listing Upgrade

Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

April 16, 2026 8:00 AM

Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of...

Read more
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
Healthcare & PharmaceuticalProduct Announcements

Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study

April 16, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics engineered to minimize abuse and overdose risk, today announced Investigational Review Board (IRB) approval to initiate Part 3 of the PF614-MPAR-102 clinical study, marking the final stage in this study evaluating its novel MPAR® (Multi-Pill Abuse Resistance)...

Read more
Black Book Warns Boards: Healthcare Supply Chain IT Has Become a Margin-Control Issue
Healthcare & PharmaceuticalProduct Announcements

Black Book Warns Boards: Healthcare Supply Chain IT Has Become a Margin-Control Issue

April 16, 2026 7:55 AM

Black Book Research today reported that healthcare supply chain is no longer a back-office purchasing function but a board-level margin-control issue, with new 2026 data showing providers are still reviewing one of their largest non-labor margin levers too infrequently to manage the risk effectively.The firm's new 75-page market e-book, The State of Healthcare Supply Chain Technology 2026, shows that hospitals and health systems are being forced...

Read more
American College of Osteopathic Family Physicians Announces 2026-2027 Board of Governors
Healthcare & PharmaceuticalManagement Changes

American College of Osteopathic Family Physicians Announces 2026-2027 Board of Governors

April 16, 2026 7:00 AM

The American College of Osteopathic Family Physicians (ACOFP) announces its new Board of Governors, following their election on Wednesday, April 15, 2026, during the ACOFP Congress of Delegates in Orlando, Florida. New appointments include:President Greg D. Cohen, DO, FACOFP dist.President-Elect David A. Connett, DO, FACOFP dist.Secretary/Treasurer Saroj Misra, DO, FACOFP dist.Governor Lynn M. Wilson, DO, FACOFPNew Physician-in-Practice Governor...

Read more
NHI Announces First Quarter 2026 Earnings Release and Conference Call Dates
Healthcare & PharmaceuticalEarnings

NHI Announces First Quarter 2026 Earnings Release and Conference Call Dates

April 16, 2026 6:00 AM

National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2026. NHI plans to issue its earnings release after the market closes on Monday, May 4, 2026, and will host a conference call on the following day, Tuesday, May 5, 2026, at 10:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the access code...

Read more
Dr. Andrea Joy Smith to Speak at Dental Practice Mastery’s Breakthrough 2026 in Newport Beach
Healthcare & PharmaceuticalConferences

Dr. Andrea Joy Smith to Speak at Dental Practice Mastery’s Breakthrough 2026 in Newport Beach

April 15, 2026 7:55 PM

Renowned dentist, educator, and implant-focused clinician Dr. Andrea Joy Smith, DICOI, has been announced as a featured speaker at Breakthrough 2026, the premier live event hosted by Dental Practice Mastery. The highly anticipated in-person experience will take place Oct. 22-25, 2026, at the luxurious VEA Newport Beach, A Marriott Resort & Spa.Designed as an immersive, high-impact continuing education experience, Breakthrough 2026 will bring...

Read more
Greg D. Cohen, DO, FACOFP dist., Named 2026-2027 President of the American College of Osteopathic Family Physicians
Healthcare & PharmaceuticalCompany Update

Greg D. Cohen, DO, FACOFP dist., Named 2026-2027 President of the American College of Osteopathic Family Physicians

April 15, 2026 7:00 PM

The American College of Osteopathic Family Physicians (ACOFP) announced that Greg D. Cohen, DO, FACOFP dist., has begun his one-year term as president after being installed in the office during the ACOFP's 63rd Annual Convention & Scientific Seminars in Orlando, Florida."I am honored, grateful, excited, and humbled to be given the opportunity to serve as President of the ACOFP," said Dr. Cohen. "In the year ahead, I hope to help our members...

Read more
Dreamtime Dentistry Champions Patient Comfort and Access to Modern Dental Care in Vista, California
Healthcare & PharmaceuticalCompany Update

Dreamtime Dentistry Champions Patient Comfort and Access to Modern Dental Care in Vista, California

April 15, 2026 6:05 PM

Dreamtime Dentistry, founded by Dr. Ryan Watkins, is raising awareness of the importance of accessible, comfortable, and modern dental care-encouraging patients to take a more proactive role in their oral health while highlighting how technological advancements are transforming the dental experience.With nearly half of adults in the United States avoiding dental visits due to fear, anxiety, or discomfort, according to the American Dental...

Read more
Avant Brands Announces its Annual General and Special Meeting
Healthcare & PharmaceuticalCompany Update

Avant Brands Announces its Annual General and Special Meeting

April 15, 2026 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU) ("Avant" or the "Company"), is pleased to announce its upcoming annual general and special meeting (the "Meeting") of the shareholders of the Company (the "Shareholders") to be held on May 4, 2026.The notice of Meeting and the management information circular (the "Circular") is available to Shareholders on Avant's website as well as under Avant's profile on SEDAR+ at www.sedarplus.ca. The...

Read more
ACOFP Foundation Reaches Goal for Family Medicine Forward Campaign One Year Ahead of Schedule
Healthcare & PharmaceuticalCompany Update

ACOFP Foundation Reaches Goal for Family Medicine Forward Campaign One Year Ahead of Schedule

April 15, 2026 2:30 PM

The American College of Osteopathic Family Physicians (ACOFP) Foundation announced today that its Family Medicine Forward campaign has reached its $750,000 fundraising goal in only two years, a year before its 2027 target. This campaign aims to provide expanded leadership development support for early career osteopathic family physicians and future leader alumni, as well as address critical barriers within the profession, including increased...

Read more
SoftWriters Launches FrameworkLTC+(TM) to Power Next-Era of AI-Driven Pharmacy Operations
Healthcare & PharmaceuticalCompany Update

SoftWriters Launches FrameworkLTC+(TM) to Power Next-Era of AI-Driven Pharmacy Operations

April 15, 2026 12:10 PM

SoftWriters today announced the launch of FrameworkLTC+™, a major advancement in its flagship platform, FrameworkLTC®. FrameworkLTC+ introduces fully integrated, AI-driven automation built for clinical-grade accuracy, enterprise-scale performance, and production-grade reliability and security.This new solution transforms long-term care (LTC) pharmacy operations, starting with one of the most manual and error-prone workflows: prescription order...

Read more
Dentures and Partials Take Center Stage at 2026 Glidewell Symposium
Healthcare & PharmaceuticalConferences

Dentures and Partials Take Center Stage at 2026 Glidewell Symposium

April 15, 2026 11:00 AM

Glidewell hosted its latest symposium on April 10-11 at the company's campus in Irvine, California. The sold-out "Dentures and Partials: Mastering the Foundational Skills" was the second of thirteen Glidewell Symposium events scheduled for 2026, drawing 200 dental professionals eager to strengthen their expertise in removable prosthodontics through expert-led sessions and practical learning opportunities.The two-day format began with focused...

Read more
Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments
Healthcare & PharmaceuticalEarnings

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

April 15, 2026 9:25 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today reported financial results for the full year ended December 31, 2025, delivering the strongest annual revenue performance in the Company's history.Full Year 2025 Financial HighlightsPerformance was marked by all-time high revenue, significant gross profit expansion, and margin improvement, driven by strong...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?